Cullen/Frost Bankers’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,190
Closed -$149K 1165
2020
Q4
$149K Buy
1,190
+70
+6% +$7.83K ﹤0.01% 526
2020
Q3
$114K Hold
1,120
﹤0.01% 541
2020
Q2
$109K Buy
1,120
+899
+407% +$83.7K ﹤0.01% 526
2020
Q1
$18K Sell
221
-802
-78% -$78.2K ﹤0.01% 657
2019
Q4
$114K Buy
1,023
+614
+150% +$63.2K ﹤0.01% 489
2019
Q3
$40K Buy
409
+286
+233% +$28.4K ﹤0.01% 604
2019
Q2
$12K Hold
123
﹤0.01% 812
2019
Q1
$14K Buy
+123
New +$12.9K ﹤0.01% 720

Other funds holding PRAH

Cullen/Frost Bankers's PRAH Position: Q1 2021 in Review

Cullen/Frost Bankers sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2021, closing a stake of 1,190 shares — an estimated $149K sold.

Cullen/Frost Bankers first reported a position in PRAH in Q1 2019 and held it in 8 quarters. The position peaked at $149K in Q4 2020. 324 funds tracked by Wall St. Rank hold PRAH as of Q1 2021.

  • Cullen/Frost Bankers reported no remaining PRA Health Sciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • Cullen/Frost Bankers sold 1,190 PRA Health Sciences, Inc. shares in Q1 2021, an estimated $149K.
  • Cullen/Frost Bankers first reported a position in PRA Health Sciences, Inc. in Q1 2019 and held it in 8 quarters.
  • Cullen/Frost Bankers's PRA Health Sciences, Inc. position peaked at $149K in Q4 2020.
  • 324 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2021.

Based on Cullen/Frost Bankers's 13F filing for Q1 2021, filed 5 May 2021.